PRospective Study to Measure the Impact of MammaPrint on Adjuvant Treatment in Hormone Receptor-positive HER2-negative Breast Cancer Patients (PRIMe)
Status: COMPLETED
Study type: OBSERVATIONAL
Conditions: Breast Cancer
Interventions: OTHER: MammaPrint|OTHER: BluePrint|OTHER: TargetPrint
Sponsor: West German Study Group
Collaborators: Agendia